HSP90B1 and neoplasm: Besides confirming that Grp94 is the tumor antigen shared by different histological types of tumors of the GI tract, we proved that it can be measured in plasma of cancer patients in complexes with IgG, serving as diagnostic tumor biomarker with the additional property to modulate the inflammatory response in circulating immune cells.